Provided by Tiger Trade Technology Pte. Ltd.

Tencent Music

9.43
-0.0600-0.63%
Post-market: 9.470.0400+0.42%19:59 EDT
Volume:11.15M
Turnover:106.32M
Market Cap:14.61B
PE:9.26
High:9.68
Open:9.48
Low:9.40
Close:9.49
52wk High:26.70
52wk Low:9.36
Shares:1.55B
Float Shares:573.97M
Volume Ratio:0.84
T/O Rate:1.94%
Dividend:0.19
Dividend Rate:1.98%
EPS(TTM):1.02
EPS(LYR):1.02
ROE:14.86%
ROA:7.97%
PB:1.26
PE(LYR):9.26

Loading ...

Tencent Music falls -10.6%

TIPRANKS
·
Nov 12, 2025

Stock Track | Tencent Music Plummets 9.64% Despite Strong Q3 Results, Puzzling Investors

Stock Track
·
Nov 12, 2025

U.S.-Listed Shares of Tencent Music Entertainment Group Fall 6% After Q3 Results

THOMSON REUTERS
·
Nov 12, 2025

Tencent Music's Growing Paying User Base Cushions Listener Decline

Benzinga
·
Nov 12, 2025

Tencent Music reports Q3 EPS 22c vs. 14c last year

TIPRANKS
·
Nov 12, 2025

Tencent Music Reports Strong Q3 2025 Financial Results

TIPRANKS
·
Nov 12, 2025

Tencent Music Entertainment's Q3 Non-IFRS Earnings, Revenue Rise

MT Newswires Live
·
Nov 12, 2025

U.S.-Listed Shares of Tencent Music Entertainment Group up 2.8% Premarket After Q3 Results

THOMSON REUTERS
·
Nov 12, 2025

Premarket Movers | Upexi Rallies 7% on Record Earnings; Tencent Music Jumps 4%; Sony Gains 3%; Nuscale Power, Oklo Rise over 2%

Tiger Newspress
·
Nov 12, 2025

Stock Track | Tencent Music Surges 5.11% Pre-market Following Strong Q3 Earnings Beat

Stock Track
·
Nov 12, 2025

Tencent Music Enter Gr Q3 Adj. EPS $0.22 Beats $0.20 Estimate, Sales $1.190B Beat $1.110B Estimate

Benzinga
·
Nov 12, 2025

Stock Track | Tencent Music Soars 6.84% Following Strong Q3 Earnings Report

Stock Track
·
Nov 12, 2025

Stock Track | Tencent Music Soars 6.84% as Q3 Results Beat Expectations with 20.6% Revenue Growth

Stock Track
·
Nov 12, 2025

Tencent Music Entertainment Group Reports Q3 Revenue of RMB8.46 Billion and Net Profit of RMB2.15 Billion

Reuters
·
Nov 12, 2025

Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC

GlobeNewswire
·
Nov 10, 2025

Verrica Pharmaceuticals Presents New Data on VP-315 from its Phase 2 Clinical Trial in Basal Cell Carcinoma at the 40th Society for Immunotherapy of Cancer Annual Meeting

GlobeNewswire
·
Nov 10, 2025

Stock Track | Tencent Music Plummets 5.33% Amid Broader Sell-off in Chinese ADRs

Stock Track
·
Nov 07, 2025

Chinese ADRs Drop With XPeng Down 6%, Alibaba Down 3%

Tiger Newspress
·
Nov 07, 2025

Press Release: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Dow Jones
·
Nov 07, 2025

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

GlobeNewswire
·
Nov 07, 2025